Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Solomon Jalang Achiek Jalang

MSc in Pharmacology

Solomon Jalang Achiek Jalang is a chemical engineering graduate from South Sudan, currently pursuing an MSc in Pharmacology at the Department of Pharmacology, University of Oxford. He is a Mastercard Foundation Scholar at the University of Oxford and a member of University College. Solomon is passionate about advancing pharmacological research and innovation to improve healthcare in under-resourced communities across Sub-Saharan Africa.

He graduated with first-class honours in Chemical Engineering, achieving a GPA of 3.84/4.0 and ranking in the top 1% of his cohort. During his studies, he received awards including Most Influential Innovative Speaker from the Inventify Center and Best Junior Project Assistant Researcher from the Chemical Engineering department, with the research group working on renewable energy. Solomon co-authored a published article on plasma technology for ammonia fertiliser production and contributed to research on nanoparticle-based drug delivery for cancer therapy. Professionally, he worked as a Junior Process Engineering Intern at PPSDM Cepu Oil Refinery and was certified as a Crude Distillation Unit Technician. He also held an assistant research internship at Daewoong Research Institute (ITB). Solomon co-founded an NNGO and currently serves as Deputy Departmental Head of Planning, Development and Innovation at Education Needs All (ENA), building experience in stakeholder engagement and project management.

Solomon’s early education journey began in a cattle camp before he moved into formal schooling, inspired by his father and grandfather. His father’s diagnosis with early-onset dementia in 2019 fuelled his interest in neurological drug development.

At Oxford, he aims to deepen his expertise in pharmacological sciences, connect with global researchers and entrepreneurs, and ultimately establish research institutions that influence health policies and shape pharmaceutical innovation across Africa.